Teva Says Dr. Reddy's Broke Deal Over Birth Control Device

By Adam Lidgett (November 17, 2021, 4:43 PM EST) -- Teva Pharmaceuticals says it is owed more than $31 million after Dr. Reddy's refused to pay for batches of a generic version of birth control device NuvaRing and then declined to pay for carrying costs, according to a new lawsuit in New York state court.

In a Monday complaint, Teva Pharmaceutical Industries Ltd. sued Dr. Reddy's Laboratories SA for breach of contract and breach of implied covenant of good faith and fair dealing, asking for no less than $31.4 million.

Teva said it struck a deal in 2016 in which Dr. Reddy's agreed to buy a generic version of NuvaRing that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!